If the primary effect of FGF21 is an increase in body temperature setpoint rather than an increase in energy expenditure, the translational perspectives of FGF21 treatment as an anti-obesity strategy would be less promising. The gene discussed is FGF21; the disease is obesity due to melanocortin 4 receptor deficiency.